Access to Cayston^© in Ontario

As of Friday, September 28th, Cayston^© will be listed on the Ontario Drug Benefit Formulary and will be available through the Exceptional Access Program. The EAP reimbursement criteria will be available as of September 28th at: http://www.health.gov.on.ca/english/providers/program/drugs/pdf/frequently_requested_drugs.pdf.

Cayston© is now also available for cystic fibrosis (CF) patients in British Columbia through Pharmacare’s Special Authority Criteria.

As the leading advocate for Canadians with cystic fibrosis, Cystic Fibrosis Canada continues to fight for equitable access to CF therapeutic products.

Reviewed/updated: 2012-09-24